---
layout: splash
title: 동국제약 (086450)
excerpt: 동국제약의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
keywords: 동국제약, 086450
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 16,220 | <span style="color: cornflowerblue">-1.9<small>%</small></span> | Q:제약 | 13.5 | 1.4 | 1.1<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 인사돌, 복합마데카솔, 파미레이 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2007년 5월 29일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 송준호 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.dkpharm.co.kr](http://www.dkpharm.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 04&#x2011;05 | | [자기주식처분결과보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240405002972){:target="_blank"} |
| 04&#x2011;03 | | [주요사항보고서(자기주식처분결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240403003238){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![086450](/stock/images/086450.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 16,220 | <span style="color: cornflowerblue">-1.9<small>%</small></span> | <span style="color: cornflowerblue">-4.1<small>%</small></span> | <span style="color: tomato">1.6<small>%</small></span> | <span style="color: cornflowerblue">-11.6<small>%</small></span> | <span style="color: cornflowerblue">-2.0<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">2.9<small>%</small></span> | 29.5<small>%</small> | 0.10 | -19.4<small>%</small> | -8.2<small>%</small> | -0.2 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 13.5 | 1.4 | 1.1<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/086450/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=086450){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A086450&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=086450){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/086450){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/086450/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![086450](/stock/images/086450_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 2.9<small>%</small> | 29.5<small>%</small> | 0.10 | -19.4<small>%</small> | -8.2<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 4.6<small>%</small> | 29.2<small>%</small> | 0.16 | -17.9<small>%</small> | -7.2<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -22.4<small>%</small> | 22.3<small>%</small> | -1.00 | -32.5<small>%</small> | -16.8<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 12.7<small>%</small> | 21.9<small>%</small> | 0.58 | -12.7<small>%</small> | -4.3<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 0.4<small>%</small> | 23.1<small>%</small> | 0.02 | -17.0<small>%</small> | -5.8<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 2.1<small>%</small> | 23.5<small>%</small> | 0.09 | -12.2<small>%</small> | -5.9<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -9.0<small>%</small> | 23.8<small>%</small> | -0.38 | -17.1<small>%</small> | -6.0<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -4.0<small>%</small> | 21.9<small>%</small> | -0.18 | -17.1<small>%</small> | -3.8<small>%</small> |
| MACD[^fn_tech_metric_macd] | 0.2<small>%</small> | 19.6<small>%</small> | 0.01 | -13.1<small>%</small> | -6.1<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![086450](/stock/images/086450_corr.png){: .align-center}

|       | [대웅](/003090/) | [레고켐바이오](/141080/) | [대웅제약](/069620/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [알테오젠](/196170/) | [삼성카드](/029780/) | [DL](/000210/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![086450](/stock/images/086450_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}